Patents by Inventor Xiaoqun GUO

Xiaoqun GUO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240076701
    Abstract: Provided are a recombinant strain with modified gene BBD29_14900, and a method for constructing the same and use thereof, with the production of L-glutamic acid as a specific application. Further provided is a method for introducing a point mutation into the BBD29_14900 gene coding sequence in Corynebacterium or improving the expression thereof. The method can cause a bacterial strain with the mutation to increase the fermentation yield of glutamic acid. The point mutation involves a mutation of the base at position 1114 in the sequence of the BBD29_14900 gene from guanine (G) to adenine (A), and thus a substitution of aspartic acid at position 372 in the coded corresponding amino acid sequence with asparagine.
    Type: Application
    Filed: December 29, 2022
    Publication date: March 7, 2024
    Applicant: NINGXIA EPPEN BIOTECH CO., LTD
    Inventors: Fengyong MA, Aiying WEI, Gang MENG, Chunguang ZHAO, Huiping JIA, Houbo SU, Lipeng YANG, Xiaowei GUO, Bin TIAN, Xiaoqun ZHOU
  • Publication number: 20240067999
    Abstract: A recombinant strain with modified gene BBD29_11265 and a method for constructing the same are provided. The recombinant strain is a bacterium that generates L-glutamic acid, and has an improved expression of a polynucleotide encoding an amino acid sequence of SEQ ID NO: 3 or a homologous sequence thereof; the improved expression can be having a point mutation in, and an enhanced expression of the polynucleotide encoding an amino acid sequence of SEQ ID NO: 3 or a homologous sequence thereof. A genetically engineered bacterium in which the base at position 70 in the BBD29_112665 gene sequence is mutated to adenine from guanine, causing alanine at position 24 in the coded corresponding amino acid sequence to be substituted with threonine, and an engineered bacterium overexpressing the BBD29_112665 gene or BBD29_11265G70A gene are constructed in the present invention, facilitating an increase in the production and conversion rate of L-glutamic acid.
    Type: Application
    Filed: December 28, 2021
    Publication date: February 29, 2024
    Applicant: NINGXIA EPPEN BIOTECH CO., LTD
    Inventors: Aiying WEI, Gang MENG, Chunguang ZHAO, Huiping JIA, Houbo SU, Lipeng YANG, Xiaowei GUO, Bin TIAN, Fengyong MA, Xiaoqun ZHOU
  • Publication number: 20210143516
    Abstract: A lead-acid battery includes a container and an intermediate cover. The container comprises six pole groups in linear arrangement in a longitudinal direction. Two of the pole groups on a farthest edge are provided with pole posts penetrating through the intermediate cover. The intermediate cover is fixed with two connection terminals. Each of the connection terminals comprise a first connecting part connected to the pole post and a second connecting part connected to an external wire. The two connection terminals are provided on a side of the intermediate cover in a width direction of thereof, and the second connecting part is led out from a side surface of the intermediate cover. One of the connection terminals is directly connected to one of the pole posts, and the other one of the connection terminals is connected to another one of the pole posts via an adapted cable.
    Type: Application
    Filed: May 23, 2017
    Publication date: May 13, 2021
    Applicant: TIANNENG BATTERY GROUP CO., LTD.
    Inventors: Guoyou HOU, Tianren ZHANG, Haimin ZHAO, Wenwei ZHOU, Mingxue FANG, Genfang GAO, Yuenan LI, Fei DAI, Xiaoqun GUO, Shu HU